Obesity Clinical Trial
Official title:
Obesity and Pregnancy : Study of Factors Influencing Participation in a Program Combining Physical Activity and Nutritional Counseling
Background:
Obesity increasingly affects young women and contributes to increased maternal, fetal and
neonatal complications. Maternal obesity contributes to the subsequent development of
childhood obesity not only through social and environmental mechanisms but also through
biological processes referring to the original concept of the developmental health and
disease. Data suggest that management during pregnancy through nutrition counseling and
adequate physical activity will help to break the familial vicious circle of obesity. To help
program to be effective it is important to understand the factors that modulate
participation. However, few studies have been conducted to assess the determinants that
influence participation.
Goal:
The main objective is to analyze 15 factors that influence participation in a program
combining physical activity and nutritional counseling among pregnant women with BMI ≥ 25
kg/m2. Secondary objectives are :
- to identify the data that influence adherence and to show that assiduous women will have
a better control of weight gain and a reduction of maternal and fetal complications.
- to understand the biological mechanisms involved
Strategy and method:
A prospective research evaluating the participation in an educational program, including
nutritional support and adequate physical activity, will be offered to overweight and obese
pregnant women. The program will last 12 weeks, and will include three workshops on diet of
the pregnant and lactating women, and the young child. Physical activity sessions will be
offered once a week. Fifteen independent variables likely to influence participation will be
analyzed. The association between participation and the risk of maternal and fetal pregnancy
complications related to obesity will be analysed. Meanwhile, more fundamental research will
be considered to determine of the biological factors involved.
This is a prospective study that will be conducted in pregnant women with a BMI ≥ 25 kg/m2,
aged from 18 to 42 years. Participation in the program will be offered between 12 and 22 + 6
weeks of pregnancy. Women with a history of more than 2 miscarriages, severe heart disease
(arrhythmia, previous myocardial infarction), bleeding in the first trimester, multiple
pregnancy, unstable thyroid disease, hypertension, diabetes, or any other medical conditions
that can interfere with the practice of physical activity during pregnancy will not be
allowed to participate in the program for medical reasons. The participants will sign an
informed consent. The intervention will be an educational program called "Eat well, move well
for to the baby's health," including nutritional counselling and physical activity exercises.
The control group will receive usual care as a simple information. The intervention will take
place between 24 and 36 weeks of pregnancy. Women will be evaluated before (20-24 weeks
gestation (SA)), during the intervention (32-34 SA), and finally 8 weeks after childbirth
during the postnatal visit. All patients with benefit from obstetric monitoring according
with the French recommendations with a monthly consultation and ultrasonography exams at 22
and 32 wks.
Nutritional support will include 3 workshops of 2 hours within the 12 weeks (one workshop per
month). Each workshop session will be conducted in groups of 10 to 15 participants. These
workshops will aim firstly to inform patients of weight gain recommendations during pregnancy
and food recommendations.
Workshop No. 1 will provide information on the goals of weight gain during pregnancy, and
will target the implementation of recommendations in terms of diet during pregnancy. The
messages will be specifically adapted to the population of obese women including dietary
advices, work on erroneous beliefs and representations, work on the motivation to change
eating habits and reduction of the harmful link between emotions and eating. Thus, beyond the
information, this workshop will have the primary role to develop a diet suitable for
pregnancy in obese women. This workshop will be led by a dietician and psychologist. It will
take place between the 1st and 4th week of the program.
Workshop No. 2 will inform the benefits of breastfeeding for the child and the mother
(including its impact on weight loss during the postpartum period, especially important in
obese women). As in the previous workshop, the objective will be to obtain the application of
the recommendations on diet during breastfeeding. The general message will be adapted to the
problems specific to obese women: work on the social, educational, family, removal of beliefs
and motivational brakes. This workshop will be led by a dietician and a midwife and will take
place between the 5th and 8th week of the program.
Workshop No. 3 will target the diet in the postpartum period and nutritional needs of the
newborn and young child. Beyond dietary information, specific work will be done on motivation
to take care of the body after pregnancy and breastfeeding, and especially the fight against
the beliefs of the food needs of the newborn, typically found in obese mothers (fear of
missing, hunger equated with suffering, the emotional power as substitute) This workshop will
take place between the 9th and 12th week of the program and will be led by a dietician and a
pediatric nurse.
The exercise program will feature sessions developed by the North Committee of the French
Federation of Physical Education and Voluntary Gymnastics. On the program, which lasts 12
weeks per patient, there will be inputs and outputs permanent in the group based on
inclusions. The program will be continued for the duration of the research. This program will
propose 3 weekly slots of physical activities so that participants can take at least a weekly
session. Ideally they will be encouraged to practice a second session and to perform
exercises by their own. The personal session can be a walk on the weekend, or an indoor gym
classes in one a club, an aqua fit session ... or exercises proposed by the coach to
replicate at home. The participants will be able to record and monitor their practice using
the logbook.
Evaluation of the program "Eat well, move well for the baby's health" The investigators will
do the assessment before during and after the program. Patients will have a logbook in which
they will notice physical activity performed. This book will include questionnaires to
complete.
1. Food Evaluation The investigators will use a food behavior questionnaire (18 items) and
5 direct questions for a semi-quantitative assessment (sweet beverages consumption, fat,
portion sizes). All these elements for assessing eating behavior (uncontrolled eating,
hunger, cognitive restriction), the type of food consumed (carbohydrates, fats and
proteins). The evaluation will be conducted by dieticians.
2. Evaluation of physical activity Physical activity of patients will be estimated using
the French Physical Activity Questionnaire in Pregnancy (QFAPG). This self administered
questionnaire will have a qualitative vision (business type) and quantitative activity
through 33 questions on "sports" on "household activities " on "activities at work " and
also on "activities related to transportation".
Physical activity will be quantitatively measured for each patient who will receive an
accelerometer (The Actigraph, Manufacturing Technology Inc., model wActisleep +,
Pensacola, Florida USA) that will record the intensity of the efforts made during a
period of 7 days.
3. Well-being Evaluation Well-being will be evaluated using the positive and negative
affect schedule Questionnaire. which is sensitive to changes over time and assesses the
positive and negative affects. It will assess the program's impact on the positive /
negative affect.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |